Farid A. Hadi

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis.

Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis.

Journal: European urology open science

Published: March 27, 2026

Reply to Beyond Anticholinergic Burden: An Integral Theory Perspective on Overactive Bladder - A Commentary on "A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South Korea".

Reply to Beyond Anticholinergic Burden: An Integral Theory Perspective on Overactive Bladder - A Commentary on "A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South Korea".

Journal: International neurourology journal

Published: December 05, 2025

Efficacy and Safety of Mirabegron in Males with Overactive Bladder and Lower Urinary Tract Symptoms: Analysis from an Integrated Database.

Efficacy and Safety of Mirabegron in Males with Overactive Bladder and Lower Urinary Tract Symptoms: Analysis from an Integrated Database.

Journal: European urology open science

Published: October 03, 2025

Targeted literature review of concepts related to women's experiences and perceptions of vasomotor symptoms associated with menopause.

Targeted literature review of concepts related to women's experiences and perceptions of vasomotor symptoms associated with menopause.

Journal: Menopause (New York, N.Y.)

Published: May 16, 2025

A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South Korea.

A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South Korea.

Journal: International neurourology journal

Published: May 02, 2024

Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH).

Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH).

Journal: Advances in therapy

Published: August 17, 2023

An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder.

An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder.

Journal: Asian journal of urology

Published: August 16, 2023

A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study.

A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study.

Journal: Neurourology and urodynamics

Published: November 17, 2022

Mirabegron has longer treatment persistence than antimuscarinics: Real-world data from a Korean national cohort database.

Mirabegron has longer treatment persistence than antimuscarinics: Real-world data from a Korean national cohort database.

Journal: Neurourology and urodynamics

Published: February 12, 2021

Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).

Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).

Journal: ESC heart failure

Published: March 17, 2017

The modern implementation of patient blood management (PBM) in Malaysia: the use of intravenous iron in severe anaemia with iron deficiency - A Case Report.

The modern implementation of patient blood management (PBM) in Malaysia: the use of intravenous iron in severe anaemia with iron deficiency - A Case Report.

Journal: The Medical journal of Malaysia

Published: March 04, 2017

Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF).

Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF).

Journal: ESC heart failure

Published: February 24, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026